SkinBioTherapeutics commercial launch could transform business

SkinBioTherapeutics (LON: SBTX) launched the AxisBiotix-Ps food supplement in the UK and US on 29 October. This psoriasis treatment is the company’s first commercial product, and it could generate cash to further develop other products.

The AIM-quoted microbiome-based skin treatments developer launched the AxisBiotix-Ps food supplement on World Psoriasis Day. The company is selling the sachets directly.

A successful study was completed for AxisBiotix-Ps earlier this year and three-quarter...

You are unauthorized to view this page.

Latest News

More Articles Like This

Tagdiv Cloud library - template content.